Avicenna Days 2022 Programme

Tuesday 15 February 2022

Time: 14.00 – 18:30 CET / 13.00 - 17.30 BST / 18.30 - 23.00 IST / 8.00 - 12.30 EST / 7.00 - 11.30 CST

 

14:00 - 14:05          Welcome

                                   Roberta Maggi, Office Manager, Avicenna Alliance

14:05 - 14:20          Introduction to Avicenna Alliance

                                 Thierry Marchal, Secretary General, Avicenna Alliance

    

14:20 - 15:00         The Vision

                                 Creating a Modeling-Based Culture, Randy Schiestl, Boston Scientific

                                 Big data, AI and in silico trials based on multiscale modelling and simulation, Blanca Rodriguez, University of Oxford

                                 Role of Modeling and Simulation in Drug Development and Regulatory Decision-Making, Raj Madabushi, FDA

                            Modeling and Simulation at the FDA, Pras Pathmanathan, FDA

   

15:00 - 15:40         The Achievements

                                 C4Bio - Community Challenge towards Consensus on the Characterization of Biological Tissue, Nele Famaey, KU Leuven, Chair of

                                 Tissue Characterization Task Force

                                 Engaging with Notified Bodies and other European Stakeholders, Simon Sonntag, Virtonomy, Chair of Notified Bodies Task Force

                                 Towards Global Harmonization - A Framework that Makes the Game Work, Marc Horner, Ansys, Chair of Global Harmonization

                                 Task Force

    

 15:40 - 15:55         BREAK

    

 15:55 - 17:25         From a Technology Dream to a Regulatory Routine: an Ongoing, Successful Journey

                                Sharing the Progress on In silico with the world, Mark Palmer, Medtronic, Leader of the International Affairs Working Group and

                                the International Affairs team;

                                Adoption of in silico methods for European Regulatory Activities, Emmanuelle Voisin, VCLS, Leader of the Policy Development

                                 Working Group and the Policy Development team;

                                Avenues for funding and coordinating in silico Research, Liesbet Geris, VPHi, Leader of the Research & Technology Working Group

                                 and the Research and Technology team.

           

17:25 - 18:15        Round Table

                               The Avicenna Alliance Board will answer your questions and openly discuss key obstacles, opportunities, progress and achievements

                               in front of us.

 

18:15 - 18:30        Wrap up

                               Thierry Marchal, Secretary General, Avicenna Alliance

    

Wednesday 16° February 2022

Time: 14.00 – 17:30 CET / 13.00 - 16.30 BST / 18.30 - 22.00 IST / 8.00 - 11.30 EST / 7.00 - 10.30 CST

    

14:00 - 14:05        Welcome & Introduction

                                Thierry Marchal, Secretary General, Avicenna Alliance

    

14:05 - 15:05        Regulatory Affairs Forum

                                In Silico in Practice: the view of Developers and Regulators

                                Speakers:

                           Alejandro Frangi, University of Leeds, Chair of the UK Insilico Regulatory Task Force

                                Francesco Pappalardo, University of Catania, Chair of the Pharmaceutical Strategy Task Force

                           Michael Kipping, Innovate UK

                                Moderator:

                                Thierry Marchal, Ansys, Secretary General of the Avicenne Alliance

 

15:05 - 16:05        Regulatory Affairs Forum

                                Harmonization & Standardization: Where do we stand?

                                Speakers:

                                Klaus Zeier, DIN

                                Luca Emili, InsilicoTrials, Chair of the Good Simulation Practice Task Force

                                Walter Schmidt, Stryker

                           Angel Guzman Rodriguez, ASME

                                Moderator:

                                Marc Horner, Ansys, Chair of the Global Harmonization Task Force

 

 16:05 - 16:15         BREAK

 

 16:15 - 17:15        Regulatory Affairs Forum

                           Raising Awareness: involving non-engineering communities

                           Speakers:

                                Claudio Capelli, GOSH, Chair of the Clinical Community Outreach Task Force

                                Cyrille Thinnes, NUI Galway, Chair of the Public & Patient Involvement Task Force

                                Michael Kipping, Innovate UK

                                Steven Levine, Dassault Systèmes, Chair of the Public & Patient Involvement Task Force

                                Moderator:

                            Cécile Rousseau, VCLS, Key member of the Avicenna Alliance 

17:15 - 17:30        Wrap up

                                Thierry Marchal, Secretary General, Avicenna Alliance

 

Register today!

 

 

Avicenna Alliance news

THE ROLE OF ARTIFICIAL INTELLIGENCE WITHIN IN SILICO MEDICINE

A range of authors across academia and industry, representing both the Avicenna Alliance and the Virtual Physiological Human Institute,...

find out more ›

Toward a regulatory pathway for Using in Silico Trials in CE Marking of Medical Devices

 

A team of researchers of the In Silico World project, including several key Avicenna Alliance members, led...

find out more ›

Avicenna Alliance response to the ICHE11A Consultation

The Avicenna Alliance strongly supports and welcomes the ICH’s proposed goal of harmonizing methods and strategies for improved paediatric drug...

find out more ›

Avicenna Alliance Feedback to the European Health Data Space Call for Feedback

The Avicenna Alliance welcomes the proposal for the EHDS. The Alliance is a multistakeholder group with the mission of...

find out more ›

We are honored to welcome Zimmer Biomet as a new Avicenna’s member!

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve...

find out more ›

Avicenna Alliance Response to 2023 Stakeholders' Targeted Consultation on EU4Health

The Avicenna Alliance stressed the need for further support and guidance for digital evidence from in silico...

find out more ›

New Avicenna APAC Task Force

A new Task Force joined the International Affairs Working Group!

find out more ›

Cécile De Coster is the new Avicenna Pharmaceutical Strategy Task Force Co-chair

We are proud to welcome Cécile De Coster as the new Avicenna Pharmaceutical Strategy Task Force co-chair!

find out more ›

Avicenna Alliance goes on growing by welcoming Edwards Lifesciences as a new member!

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and...

find out more ›

Avicenna Alliance is honoured to welcome Alfasigma as a new member!

Privately owned, Alfasigma is one of the leading Italian pharmaceutical companies, present in over 90 countries, through...

find out more ›

EU-funded project successfully develops AI software that grows and treats cancerous tumors 

The Horizon Europe 2020 project EVO-NANO (Evolvable platform for programmable nanoparticle-based cancer...

find out more ›

In silico used to validate Omicron variant detection method! 

The Joint Research Centre (JRC) has developed a new method to detect the Omicron variant of COVID-19, which differs in its nucleic acid...

find out more ›

The priorities of the upcoming French Presidency of the Council of the European Union - what’s new for Avicenna? 

The French Presidency of the Council of the European Union is due to start on 1...

find out more ›

New Avicenna UK Insilico Regulatory Innovation Task Force

The Avicenna International Affairs Working Group adds a new task force to its structure.

find out more ›

In Silico in Innovation – again!

The European Innovation Council (EIC) has released its second wave of “start-up champions” to receive funding for innovations through the EIC Accelerator. The EIC...

find out more ›

Avicenna Alliance meets with MEPs to discuss in silico medicine

On 7 October, Dr. Liesbet Geris (Research Professor in Biomechanics and Computational Tissue Engineering at the Universities of Liège &...

find out more ›

The Joint Research Centre advocates for a “paradigm change” to in silico research methods!

For the second week in a row, the Joint Research Centre (JRC) – part of the European Commission’s EU Science...

find out more ›

The European Commission Joint Research Centre publishes a public knowledge base of non-animal models used in immuno-oncology

The Joint Research Centre (JRC), which is part of the European...

find out more ›

The State of the (European) Union

On 15 September, Commission President Ursula von der Leyen delivered her second State of the Union speech at the European Parliament in Strasbourg. She took stock of...

find out more ›

The BECA Beat 

The European Parliament’s Special Committee on Beating Cancer (BECA) met for the first time in September of 2020. BECA was established to create actionable recommendations for Member...

find out more ›

Avicenna Alliance prepares for the next EU policy session 

As September begins, politicians have returned to their EU posts and are preparing for what will be a busy few months for health policy. The...

find out more ›

Joint Research Centre of the Commission launches report on national strategies for Artificial Intelligence!

The Joint Research Centre of the European Commission (JRC) recently published a new report...

find out more ›

Conference of the Slovenian Council Presidency addresses digital twin technologies and digitalisation in healthcare!

On 15 and 16 July, the Slovenian Presidency of the Council of the European Union ...

find out more ›

WHO issues first global report on use of AI in healthcare

Artificial Intelligence (AI) applications in health innovation are rapidly increasing, reflecting the potential of these technologies to...

find out more ›

Slovenian Presidency of the Council of the EU launches its six-month programme!

On 1 July, for the second time since joining the EU in 2004, Slovenia has taken over the Presidency of the Council of...

find out more ›

Members of the European Parliament call EU Health Commissioner to place in silico medicine on her policy agenda from 2021 onwards!

On 22 June, a group of five Members of the European Parliament...

find out more ›

Our new position paper on in silico evidence in the regulatory approval of medical devices is out!

The Avicenna Alliance is proud to announce the recent publication of its new position paper...

find out more ›

Happy 5th Anniversary to the Avicenna Alliance!  

5 years ago, based on the very enlightening Avicenna Roadmap Project Report, the Avicenna Alliance was established at the suggestion of European...

find out more ›

EU New Medical Device Regulation now in force! In silico mentioned for the first time

After a one-year postponement following the COVID-19 pandemic, the European Commission’s Medical Devices...

find out more ›

The European Commission adopts Communication on Europe's global approach to cooperation in research and innovation

On 18 May, the European Commission adopted a Communication on its global approach...

find out more ›

Avicenna Alliance provides feedback on the European Commissions’ roadmap for the revision of the EU general pharmaceuticals legislation

On 27 April, the Avicenna Alliance has submitted its feedback...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up